Join us on June 15th for our First Annual Bio-innovation Summit and hear from top Life Sciences (LS) researchers, policy-makers, business leaders, and legal professionals for a discussion on how technology such as AI and predictive modelling has transformed the LS sector.

Hear from keynote speaker, Professor Jayne Lawrence, the Head of the Division of Pharmacy and Optometry at Manchester University. She will talk about the role technology plays in re-purposing drugs or finding new indications and how these technologies can influence public health policy. Later enjoy panel discussions about the IP trends in pharma and biotech and AI-guided drug discovery.

Agenda

Introduction – Opening remarks and keynote from Professor Jayne Lawrence

Panel 1 – IP Trends in Pharma and Biotech

A discussion of the most important IP topics related to LS, such as recent case law pertaining to biotech patents, trends and considerations in ANDA and other life science litigation shifts. Additionally, we will cover the complex relationship between rewarding innovation in LS through robust patent and trade secret protection and public health policy

Panel 2 – AI-guided Drug Discovery

A conversation about how the latest technologies, such as artificial intelligence and predictive modelling, are used to harness the vast and growing quantity of public disease and drug-related data. Topics may include the benefits of drug repurposing strategies to life sciences companies and to society at large, and the convergence of seemingly disparate data types in the search of new drug indications.

 

Keynote

jane-circle

Professor Jayne Lawrence, MBE

University of Manchester

Professor Jayne Lawrence is a pharmacist who, in addition to working in academia, has spent time working in community, hospital and industrial pharmacy. She is currently Head of the Division of Pharmacy and Optometry, Manchester University. Prior to this she was Professor and Head of the Pharmaceutical Biophysics Group, Institute of Pharmaceutical Science, King’s College London and Chief Scientist at the Royal Pharmaceutical Society (RPS). Over the last 25 years Professor Jayne Lawrence has pioneered the use of neutron scattering techniques in pharmaceutical science. Professor Jayne Lawrence was awarded an MBE for her service to pharmaceutical research in the 2020 Queen’s birthday honours. 

LinkedIn

Panel One

Host: Sam Wiley

Sam is a Connected Innovation Intelligence Evangelist dedicated to equipping the world’s business professionals, researchers, and creative minds with the tools and best practices to make better innovation decisions. With two decades of innovation and IP experience, Sam has consulted on front-page news IP litigation, helped the world’s top companies and law firms align its IP strategies with business objectives, and presented as a thought leader across North America, Europe, and Asia.

  • Megan Lyman

    Owner at Lyman Consulting

    LinkedIn

  • Marcel van Kooij

    Partner at Arnold & Siedsma

    LinkedIn

  • Nick Schopman

    Dutch and European Patent Attorney at Arnold & Siedsma

    LinkedIn

Panel Two

Host: Jimmy Ho

Jimmy Ho is currently a Senior Solutions Consultant specializing in Life Sciences at Patsnap. Previous to this role, he worked as a Senior Analyst for IQVIA and Clarivate Analytics on their Patent and Competitive Intelligence platforms. Jimmy holds a PhD in Gene Therapy research from University College London (UCL). He is also ABPI-qualified, and a Member of the Royal Society of Chemistry.                                                                                                                                             

  • Rich-Henry Schabowsky

    Partner at Thursday Ventures

    LinkedIn

  • Brian G. Kingwell

    Partner at Gowling WLG

    LinkedIn

  • Sudeep Basu

    Practice Leader, Innovation Services at Frost & Sullivan

    LinkedIn

  • Steve Young

    Vice President of Business Development at Sygnature Discovery

    LinkedIn
 

Fill out this form to watch the summit On-Demand